Pfizer Inc. | 7 December | 11:45–12:45 | Plenary hall
How we can harness gepants in clinical practice, today and into the future
Speakers: Jelena Pavlovic, US | Christina Tassorelli, IT | Messoud Ashina, DK
In this session we will explore the future of migraine management. Speakers will share insights on clinical evidence for the use of gepants to both treat and prevent migraine, including triptan refractory and long-term data. Engage with our expert panel in an interactive session as they discuss bridging clinical trial data to real world practice. The session will conclude with an audience Q&A.